Page 23 - David Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The City of Ocala Recreation and Parks Department will host career exploration panels starting April 4.

As Novo and Lilly fight to dominate the market in weight-loss drugs, gaining an edge in manufacturing power is emerging as a new front. Both drugmakers are racing to secure the highly specialized plants that can churn out enough of their top-selling drugs to keep up with demand.

Eli Lilly and Company (NYSE:LLY) Q4 2023 Earnings Call Transcript February 6, 2024 Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q4 2023 Earnings Call. At this time all participants are in a listen-only mode. Later, we will be conducting a question-and-answer session and instructions will be given at […]

FRANKFURT (Reuters) -The European Union's drugs regulator said on Wednesday it will investigate any risks to the availability of medicines processed at Catalent sites that will be sold to Novo Nordisk, part of its mandate to prevent drug shortages. The European Medicines Agency told Reuters in a statement that its Medicine Shortages Single Point of Contact (SPOC) Working Party will liaise with member states to gather data on the products manufactured at the sites. Novo Nordisk on Monday moved to boost output of its popular obesity drug Wegovy as its parent holding struck a deal to buy C...

Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the drugmaker expects momentum to carry into the new year